All Releases
View Summary Celldex Presents Promising Data from Phase 1/2 Study of Varlilumab and Opdivo® at 2018 ASCO Annual Meeting
Jun 2, 2018
PDF 66.3 KB Add to Briefcase
View Summary Celldex Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
Jun 1, 2018
PDF 10.2 KB Add to Briefcase
View Summary Celldex Announces Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
May 16, 2018
PDF 13.0 KB Add to Briefcase
View Summary Celldex Provides Corporate Update and Reports First Quarter 2018 Results
May 10, 2018
PDF 30.9 KB Add to Briefcase
View Summary Data from Multiple Celldex Programs Presented at American Association for Cancer Research (AACR) Annual Meeting 2018
Apr 20, 2018
PDF 63.1 KB Add to Briefcase
View Summary Celldex's METRIC Study in Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint
Apr 16, 2018
PDF 20.1 KB Add to Briefcase
View Summary Celldex Provides Corporate Update and Reports Full Year 2017 Results
Mar 7, 2018
PDF 32.0 KB Add to Briefcase
View Summary Celldex to Report Fourth Quarter and Year-End 2017 Business/Financial Results and Present at Upcoming Investor Conference
Mar 2, 2018
PDF 11.2 KB Add to Briefcase
View Summary Celldex Therapeutics Initiates Phase 1 Study of New Product Candidate CDX-1140 in Solid Tumors
Nov 30, 2017
PDF 15.4 KB Add to Briefcase
View Summary Celldex Therapeutics Initiates Phase 2 Combination Study of CDX-3379 and Cetuximab in Head and Neck Squamous Cell Carcinoma
Nov 17, 2017
PDF 55.0 KB Add to Briefcase
View Summary Celldex Reports Third Quarter 2017 Results
Nov 7, 2017
PDF 75.5 KB Add to Briefcase
View Summary Celldex Therapeutics Appoints Margo Heath-Chiozzi, M.D., as Senior Vice President, Regulatory Affairs
Oct 3, 2017
PDF 15.5 KB Add to Briefcase
View Summary Celldex Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 22, 2017
PDF 10.3 KB Add to Briefcase
View Summary Celldex Announces Departure of Chief Medical Officer
Sep 12, 2017
PDF 13.1 KB Add to Briefcase
View Summary Celldex Announces Completion of Enrollment in Phase 2b Study of Glembatumumab Vedotin in Triple Negative Breast Cancer
Aug 23, 2017
PDF 13.8 KB Add to Briefcase
View Summary Celldex Reports Second Quarter 2017 Results
Aug 8, 2017
PDF 76.6 KB Add to Briefcase
View Summary Celldex to Report Second Quarter 2017 Financial Results and Host Corporate Update Call
Aug 2, 2017
PDF 2.1 KB Add to Briefcase
View Summary Celldex Therapeutics Announces Additions to the Board of Directors and Senior Management Team
Jun 16, 2017
PDF 20.7 KB Add to Briefcase
View Summary Celldex Therapeutics to Participate in the Jefferies 2017 Global Healthcare Conference
Jun 6, 2017
PDF 12.8 KB Add to Briefcase
View Summary Celldex Therapeutics Presents Phase 1 Study of Varlilumab and Opdivo® at 2017 ASCO Annual Meeting
Jun 5, 2017
PDF 64.0 KB Add to Briefcase
Showing 1-20 of 165 Page: 1 2 3 4 5 ... 9  Next 20
Showing 1-20 of 165
Page: 1 2 3 4 5 ... 9
 Next 20
Add to Briefcase = add release to Briefcase